Valuation (38%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 2.15 | 38.28 |
| PEG Ratio (TTM) | -0.13 | 1.90 |
| P/S Ratio (TTM) | 0.22 | 2.26 |
| P/B Ratio (TTM) | 1.43 | 2.72 |
| P/FCF Ratio (TTM) | N/A | 15.25 |
| Price to 5YR AVG Earnings Ratio | N/A | 5.67 |
| Price to 5YR AVG FCF Ratio | N/A | 52.87 |
Profitability (65%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 26.34% | 7.18% |
| ROE (TTM) | 86.47% | 12.74% |
| Net Profit Margin (TTM) | 10.69% | 7.86% |
| ROIC 5YR AVG | N/A | 10.42% |
Growth (58%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 284.94% | 125.42% | N/A |
| Revenue | -0.99% | 31.19% | N/A |
| Net Income | 289.97% | 178.28% | N/A |
| Cash Flow | 81.12% | 83.23% | N/A |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.63 | 2.60 |
| Quick Ratio (TTM) | 1.62 | 2.54 |
| D/E Ratio (TTM) | N/A | 0.29 |
| Interest Coverage (TTM) | N/A | 20.96 |
| Piotroski F-Score | 6 | 6 |
| Altman Z-Score | 3.53 | 4.70 |
| LTL to 5YR AVG FCF | N/A | 6.28 |
| Shares Outstanding Growth 5YR AVG | N/A | 101.25% |